Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

Biotechnology

Therapeutics

Redona Therapeutics

Co-Founders

Kazumi Shiosaki

Deborah Smith

Edward Darr

Richard Gregory

George Daley

Frank Slack

Piotr Sliz

Shomir Ghosh

Luke Evnin

Michal Silverberg

Briggs Morrison

Henrijette Richter

Christine Brennan

Twentyeight-Seven Therapeutics' Leadership Team includes Darren Harvey and 4 others.

Leadership Team

About

People (4)

Edward Darr

Kazumi Shiosaki

Robert Bob Campbell

Shomir Ghosh

Jobs